MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.15
-0.17 (-1.50%)
At close: Dec 31, 2025, 4:00 PM EST
10.83
-0.32 (-2.83%)
After-hours: Dec 31, 2025, 7:39 PM EST
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $52.34 million as of December 31, 2025. Its market cap has increased by 110.06% in one year.
Market Cap
52.34M
Enterprise Value
43.78M
1-Year Change
110.06%
Ranking
Category
Stock Price
$11.15
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $52.34M, a decrease of -86.45%. That is a compound annual growth rate of -37.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 53.14M | 92.40% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |